Skip to main content

Cineline India Ltd. (BSE Code: 532807) (CMP: Rs.22.75)

Cineline  company  of  the Kanakia group has  9  multiplexes  in  Mumbai  which  are  leased  to  PVR  Cinemas.  Apart  from  its  own  multiplex  theatres  company’s  Eternity  Mall  in  Nagpur  was  given  for  rental  basis  to leading  brands  this  year  and  enjoys  100%  occupancy. The  Company’s  income  mainly  comprise  of  rental  income  from  multiplexes  and  the  Eternity  Mall.  The  Cineline  share  is  currently  trading  at  6  times  its  FY15  earnings  and  3  times  its  EBITDA.  It  is  available  at  cheap  valuations  as  compared  to  its  peers  ‐  PVR  &  Inox.  The  Cineline  stock  has  the  potential to give 100%  returns within a year. 

MIND-BLOWING REVIEW OF LAST WEEK

Stock
Rec. Rate
Achieved
Appreciation in %
MARAL OVER
35.70
37.25
4%
R SYSTEMS
77.95
81.05
4%
J K PAPER
44.65
48.25
8%
NAHAR POLY
49.15
59.10
20%
SHILCHAR TECH
181
202
12%
AMD IND
28.65
36
26%


Comments

Popular posts from this blog

Best Buy For Monday Upper Circuit Expected TCI FINANCE

*Intraday & Short Term News For Monday* *Fii And Dii News*   *TCI FINANCE LTD (501242 & NSE) (31)*   Incorporated in 1973, TCI Finance Ltd (TCIFL) is a Non-Banking Finance Company (NBFC) registered with the RBI and engaged in the business of Inter-Corporate Deposits, investment in equities of bodies corporate etc.   The Company was promoted by Mr. Mahendra Agarwal, who is also the Managing Director and CEO of Gati Ltd, a pioneer in express distribution and supply chain and promoted by TCFIL   The Rs.2 paid-up share of Gati Ltd currently trades at Rs.113. TCIFL has one subsidiary - ITAG Business Solutions Ltd engaged in the business of Knowledge Process Outsourcing (KPO) in the domain of Intellectual Property Services.   *It is co-promoter of GATI LTD. Company is holding 55,12,455 shares (5.09%) stake in GATI LTD. At CMP value of investments is around Rs.62.3crore. Equity is Rs.12.87crore. Thus value of investment works out to Rs.48.4 per share ...

Danlaw Technologies India Ltd: For multi-bagger gains (BSE Code: 532329) (CMP: Rs. 60.75) (FV: Rs.10)

The earnings season so far has been weak and worries over domestic growth continue to weigh on the market sentiment which has led the markets back on the downward path.. A value investor, however, need not worry about the broad markets as value stocks perform better and post good results. One such value-pick is Danlaw Technologies India Ltd. (DTIL). Company background: DTIL is the offshore technology and product development center of its parent company - Danlaw Incorporated, founded by Mr. Raju Dandu and Mr. Lloyd Lawrence in Michigan, USA in 1984. DTIL’s mission is to provide high quality services and products in Automotive Electronics, develop R&D driven Signal Processing technologies for communication and control, configure solutions and provide exceptional Information Technology (IT) services in the areas of education, health, banking and e-governance and provide world-class products and solutions for secured access through biometric access control technologies with intellige...

Some Opportunities Are left in Pharma Sector

Torrent Pharmaceuticals  reported impressive 75% growth in revenues and profit in the first quarter of FY 2016. The sterling performance was driven by the launch of new product in the US market, which has limited competition at present. The focus is on the therapeutic segments of cardiovascular and CNS. There is presence in gastro-intestinal, diabetology, anti-infective, pain management, nephrology, oncology, gynecology and pediatric segments as well. The manufacturing plants for formulations and bulk drugs have been approved by authorities of several regulated and semi-regulated markets such as the US, the UK, Brazil, Germany, Australia and South Africa. Capacity will increase almost 100% once the new plant at Dahej in Gujarat becomes operational. The plant will be one of the largest pharmaceuticals manufacturing facilities in the country at a single location. The unit will primarily cater to the key regulated markets of the US and Europe. Approval from regulators such...